Quantcast

Latest Oncologists Stories

2014-05-05 23:00:16

‘Op-Ed on Cancer’ challenges traditional approach to cancer treatment, offers author’s 35-year experience as proof. Douglaston, N.Y. (PRWEB) May 06, 2014 Experienced registered nurse and author Ann Wax provides an alternative approach to cancer treatment in the new book “Op-Ed on Cancer” (published by Balboa Press). “The traditional approach to cancer is that the patient must view cancer as the enemy and engage in a war to vanquish that enemy,” Wax says. “I believe that...

2014-05-01 23:04:55

Kia Michel, MD, of Comprehensive Urology in Los Angeles comments on the importance of seeking testicular cancer treatment after a 21-year-old’s life is saved thanks to social media platform Reddit. Beverly Hills, CA (PRWEB) May 01, 2014 Recent news that a 21-year-old’s life was saved thanks to the popular social media site Reddit underscores how testicular examinations can have a substantial – and potentially life-saving – effect on patients of any age. Taylor “Chase” Tyree...

2014-04-30 16:31:47

CAMBRIDGE, Mass., April 30, 2014 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced that Andrew R. Allen, M.D., Ph.D., co-founder and Executive Vice President of Clinical and Pre-Clinical Development and Chief Medical Officer of Clovis Oncology, Inc., has been nominated for election to the company's board of directors. The election of...

2014-04-28 12:27:57

NEW YORK, April 28, 2014 /PRNewswire/ -- Elsevier [http://www.elsevier.com ], world-leading provider of scientific, technical and medical information products and services, and the American Urological Association [http://www.auanet.org ] (AUA), a premier urological association providing invaluable support to the urology community, announce their collaboration to launch a new journal, Urology Practice [http://www.urologypracticejournal.com ]. Urology Practice will focus...

2014-04-28 08:31:20

BOTHELL, Wash. and VANCOUVER, British Columbia, April 28, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced results from the Phase 3 SYNERGY trial. Top-line survival results indicate that the addition of custirsen to standard first-line docetaxel/prednisone therapy did not meet the primary endpoint of a statistically significant improvement in overall survival in men with metastatic castrate-resistant prostate cancer (CRPC), compared to...

2014-04-24 08:34:02

Will oversee Virginia G. Piper Cancer Center's internationally recognized Phase I clinical trials program SCOTTSDALE, Ariz., April 24, 2014 /PRNewswire-USNewswire/ -- Michael S. Gordon, MD, one of the greater Phoenix area's leading medical oncologists and cancer researchers, has been named the new Medical Director for the Virginia G. Piper Cancer Center Clinical Trials program at Scottsdale Healthcare. Dr. Gordon will oversee the center's internationally recognized Phase I clinical...

2014-04-23 08:32:21

Fort Lauderdale-based event to provide stomach cancer patients and their families unparalleled access to hear from eight world-renowned experts in the field of stomach cancer FT. LAUDERDALE, Fla., April 23, 2014 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF), a non-profit organization that raises awareness and funds for stomach cancer, is proud to host its fourth annual "Stomach Cancer Education Symposium & Webinar." The live event and webinar will be held...

2014-04-23 08:31:00

Third Phase 3 Trial of Custirsen to Receive FDA Fast Track Designation BOTHELL, Wash. and VANCOUVER, British Columbia, April 23, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of custirsen when administered in combination with cabazitaxel/prednisone for the treatment of men with metastatic castrate-resistant prostate cancer (CRPC) following...

2014-04-08 00:21:50

Fox Family Cancer Research Funding Trust Is Contributing to Support Team SAN DIEGO, April 7, 2014 /PRNewswire-USNewswire/ -- Stand Up To Cancer (SU2C), The Lustgarten Foundation, and the Fox Family Cancer Research Funding Trust, along with the American Association for Cancer Research (AACR), SU2C's Scientific Partner, announced the formation of a Dream Team dedicated to pancreatic cancer research during a press event today at the AACR Annual Meeting 2014, held here April 5-9. Elizabeth M....

2014-04-03 08:30:01

Joins Renowned Academic Scientists Charles Sawyers, Jose Baselga and Ronald Evans SAN DIEGO, April 3, 2014 /PRNewswire/ -- Seragon Pharmaceuticals Inc., a clinical-stage biotechnology company focused on the development of drugs for hormone-driven cancers, today announced the expansion of the company's Clinical and Scientific Advisory Board (CSAB) and the appointment of Debasish Roychowdhury, M.D., who will serve as Seragon's Acting Chief Medical Officer....


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related